BUSINESS

Zydus Life's plans for cancer biosimilar hit a legal hurdle

ECONOMICS TIMES
7 hours ago
Read Full Article

MORE TO CATCH UP

BUSINESS

More volatility ahead: A mid-year prediction update

The writer revisits the trends he predicted at the beginning of the year. Eight of ten are spot on

THE HINDU BUSINESS LINE
43 minutes ago
STOCKS

Stock Market Live Updates 21 July 2025: Index Outlook: Nifty Midcap 150, Smallcap 250 outperform; Nifty 50, Sensex, Bank Nifty hover near key supports

Sensex, Nifty, Share Prices LIVE: Nifty 50, Sensex and the Nifty Bank index fell last week and were down in the range of 0.7-0.9 per cent. However, the Nifty Midcap 150 and the Nifty Smallcap 250 indices outperformed by rising over a per cent each. Nifty is coming down towards 24,800-24,700 as expected. Similarly, the fall to 55,900-55,800 on the N ...more

THE HINDU BUSINESS LINE
44 minutes ago
BUSINESS

Crushing injuries

Report flags systemic safety and labour compliance challenges in automobile supply chains

THE HINDU BUSINESS LINE
52 minutes ago
ECONOMY

Personal loan: avoid 5 mistakes

THE HINDU
53 minutes ago
BUSINESS

HDFC Bank Stock To React Following Q1FY26 Results, Bonus & Dividend; Should You Buy?

HDFC Bank's Q1 FY2025-26 standalone net profit rose 12.24% to Rs 18,155.21 crore. Net interest margin narrowed to 3.35%.

NEWS18
54 minutes ago
BUSINESS

Why Dilip Piramal sold VIP Industries

After nurturing the luggage firm for decades, what made the Chairman relinquish control

THE HINDU BUSINESS LINE
1 hour ago

Subscribe for latest news updates from NewsFomo

Get over your FOMO of knowing what's happening. Never miss what matters to you!